FDA
-
-
-
-
-
-
-
GE HealthCare gets FDA clearance for AI radiation therapy planning software
-
-
-
-
-
-
-
GE HealthCare begins phase 2/3 trial for manganese-based MRI contrast agent
-
-
-
-
-
-
-
How Decentralized AI is Unlocking Value in Cardiac Diagnostics
-
-
-
-
-
-
-
GE HealthCare to showcase AI and digital leadership at HIMSS 2026
-
-
-
-
-
-
-
Global AI Infrastructure Shift Ignites Biotech Growth Phase
-
-
-
-
-
-
-
GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability
-
-
-
-
-
-
-
GE HealthCare announces Flyrcado milestone: Strong pilot results drive broader rollout at CVAUSA
-
326,365 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

